查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球医疗第二意见市场
市场调查报告书
商品编码
1272771

2023-2030 年全球医疗第二意见市场

Global Medical Second Opinion Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球医疗第二意见市场预计到 2022 年将达到 43.448 亿美元，到 2030 年将达到 127.018 亿美元。 预计医疗第二意见市场在预测期内（2023-2030 年）的复合年增长率为 14.8%。 市场上的远程医疗趋势正在推动医疗第二意见市场的增长。

人们通过与医生的电话交谈来使用医疗第二意见服务，消除了患者和医生之间实际存在的需要以进行治疗。 在巴西等国家/地区，远程医疗正在帮助填补医疗保健方面的空白，使医生能够监控患者的需求并快速解决治疗延误问题。

第二医疗意见可用于确认或更改其他医生推荐的治疗策略。 第二医疗意见会对诊断、治疗政策和预后产生重大影响。 通过优化治疗策略，患者可以避免不必要的风险。 医生也较少受到法律索赔，医疗保健组织受益于改进的护理、质量控制以及从不必要的手术和治疗中节省的成本。

但是，不慎使用该技术可能会导致不合理的医疗费用。 预计在预测期内，扩大癌症和神经系统疾病新兴市场、技术进步和市场开发等因素将推动全球医疗第二意见市场的增长。

市场动态

神经系统疾病发病率上升推动医疗第二意见市场的增长

在世界许多地方，包括美国，神经系统疾病是一个严重的问题，并且其数量正在增加。 不幸的是，许多人对神经系统疾病、什么是神经系统疾病以及它们如何影响神经系统疾病患者的整体生活质量没有正确的认识。 由于此类疑难神经系统疾病的增加，市场正在蓬勃发展。

例如，根据 Classic Rehabilitation, Inc. 的数据，全世界每年有近 700 万人死于神经系统疾病，超过 10 亿人受到一种或多种神经系统疾病的影响。 因此，疾病正在增加，促使市场扩张。

缺乏认识阻碍了全球医疗第二意见市场的增长

然而，在发展中国家，目前的情况是缺乏寻求医学第二意见的知识和意愿。 大多数人认为医生的在线第二意见仅适用于严重的医疗情况。 预计这将阻碍市场增长。

COVID-19 影响分析

医疗第二意见的全球市场受益于 COVID-19，随着大流行的蔓延推动进一步增长。 由于大多数人都有涵盖医疗保健的健康保险，而且设施目前已满负荷运转，因此可能无法获得足够优质的护理。 在这种情况下，第二医疗意见确实可以帮助和协助市场。 在市场上提供的各种治疗方法中做出决定可能很困难。 为患者提供第二医疗意见以获得最有效和可靠的治疗。

俄乌衝突分析

由于该地区的渗透率低且缺乏主要市场参与者，因此估计俄罗斯-乌克兰对全球医疗第二意见市场的影响较小。 然而，原材料、试验产品和设备进出口的影响预计在预测期内对全球医疗第二意见市场影响不大。

人工智能影响分析

人工智能有望对全球医疗第二意见市场产生积极影响。 人工智能（AI）辅助诊疗规划应该有第二意见的权利，但这种权利不应该一定被解释为医生意见的权利。 另一个独立的人工智能係统或许能够满足第二意见的需要。

内容

第 1 章研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 无序片段
  • 按服务类型
  • 区域摘要

第四章市场动态

  • 影响因素
    • 主持人
      • 保护患者免于误诊
      • 神经系统疾病的发病率增加
    • 约束因素
      • 第二意见的高成本阻碍了市场扩张
    • 机会
      • 有利的政府政策为主要参与者创造商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 未满足的需求
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • 当前的 COVID-19 情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第七章俄乌衝突分析

第8章人工智能的影响分析

第9章疾病

  • 癌症
  • 糖尿病
  • 心脏病
  • 神经系统疾病
  • 眼科疾病
  • 其他

第 10 章按服务类型

  • 医院
  • 医疗第二意见提供者
  • 健康保险公司

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 竞争场景
  • 市场份额分析
  • 併购分析

第13章公司简介

  • Mediguide International LLC。
    • 公司概况
    • 产品组合和说明
    • 财务摘要
    • 主要发展状况
  • WorldCare Inc.
  • Cynergy Care
  • AXA PPP Healthcare
  • Cleveland Clinic
  • Helsana Group
  • Teladoc Health
  • GrandOpinion
  • Lybrate
  • Mass General Brigham

第14章 附录

简介目录
Product Code: HCIT2076

Market Overview

The global medical second opinion market reached US$ 4,344.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 12,701.8 million by 2030. The medical second opinion market is expected to exhibit a CAGR of 14.8% during the forecast period (2023-2030). The telemedicine trend in the market is driving the growth of the medical second opinion market.

People are using medical second opinion services through telephonic conversation with their doctors, which also eliminates the physical presence of patients and their doctors for their treatment. In countries like Brazil, telemedicine is helping to fill the healthcare gaps, allowing physicians to monitor patients' needs and eliminate treatment delays quickly.

A second medical opinion can be used to confirm or change a recommended course of therapy made by another doctor. A second medical opinion may have a significant impact on the diagnosis, course of treatment, and prognosis. By optimizing the course of treatment, the patient can avoid unneeded hazards. Less exposure to legal claims benefits doctors, while improved care, quality control, and cost savings from unneeded surgeries and treatments benefit healthcare organisations.

However, using this technology carelessly can result in irrational medical expenses. The factors such as growing cases of cancer, neurological disorders, technological advancements, and market developments are expected to boost the global medical second opinion market growth over the forecast period.

Market Dynamics

Increased incidence of neurological disorders is driving the medical second opinion market growth

In many parts of the world, including in the U.S., neurological illnesses are a severe and growing problem. Unfortunately, a lot of people do not properly comprehend neurological illnesses, including what they are and how they affect the overall quality of life for those who are affected. The market is fueled in part by the rise in neurological illnesses.

For instance, according to Classic Rehabilitation, Inc., almost 7 million individuals worldwide pass away each year as a result of a neurological ailment, and more than 1 billion people are affected by one or more neurological diseases. As a result, diseases are on the rise, which stimulates market expansion.

The lack of awareness will hamper the global medical second opinion market growth

However, in developing countries, there is a lack of knowledge and desire to seek a second medical opinion. Most people believe that online second opinions from doctors are only for serious medical situations. This is expected to hamper the market growth.

COVID-19 Impact Analysis

The global market for medical second opinions has benefited from COVID-19, which further encouraged growth as the pandemic spread. There may not be enough high-quality therapies accessible because the majority of people have health insurance that covers their care and the facilities are currently at capacity. In these cases, a second medical opinion is really helpful and assists the market. Making a decision among the wide range of treatments offered on the market is challenging. To receive the best care with the greatest effectiveness and dependability, the patient may use a second medical opinion.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine is estimated to have a minimal impact on the global medical second opinion market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of raw materials, test products, and devices is anticipated to have little influence over the global medical second opinion market over the forecast period.

Artificial Intelligence Impact Analysis

Artificial intelligence is anticipated to impact positively for the global medical second opinion market. There should be a right to a second opinion for diagnosis and treatment planning aided by artificial intelligence (AI), but this right should not always be interpreted as a right to a physician's view. Another independent AI system may be able to satisfy the need for a second opinion.

Segment Analysis

The global medical second opinionmarket is segmented based on disorder, service provider, and region.

The medical second opinion providing companies segment is estimated to hold a majority of the medical second opinion market share during the forecast period

The medical second opinion providing companies segment holds about 33.2% market share of the total medical second opinion market. Medical second opinion providing companies segment growth is driven by the companies that offer risk-free services to patients and provide medical second opinions. For instance, online second opinions from medical second opinion providers offer patients a quick, easy, and secure option to acquire responses to their inquiries concerning a diagnosis or course of therapy.

People can contact with a knowledgeable doctor who specializes in their particular medical requirements through an online second opinion programme. Additionally, the segment is also driven by corporate initiatives including partnerships and acquisitions.

For instance, on January 14, 2021, Accolade, Inc., a company that offers individualized, tech-enabled solutions to help people better understand, navigate, and use the healthcare system and their workplace benefits, announced that it entered into a legally binding agreement to acquire Innovation Specialists, LLC (d/b/a 2nd.MD), a prominent provider of expert medical advice and medical decision support services with headquarters in Houston, Texas.

Geographical Analysis

North America is estimated to hold the largest share of the global medical second opinion market during the forecast period

The North America region holds the largest share of the global medical second opinion market accounting for approximately 39.4% over the forecast period.

The use of telemedicine technologies enables communication between doctors and patients across geographic borders. During the forecast period, the market for medical second opinions is anticipated to benefit greatly from the considerable advantages of telemedicine technology and rising investments.

For instance, TeleHealth Solution (THS) received funding in March 2020 from innovative Capital Partners (NCP), a private equity company in Birmingham, Alabama, to create innovative telemedicine technology. Nursing services, long-term care, and assisted living facilities will benefit greatly from these new technology. In order to make healthcare more easily accessible to a broad number of individuals, the firm plans to establish pre-consultations, second medical opinions, and appointment-booking systems with the aid of this financing.

Competitive Landscape

The major global players in the market include Mediguide International LLC, WorldCare Inc, Cynergy Care, AXA PPP Healthcare, Cleveland Clinic, Helsana Group, Teladoc Health, GrandOpinion, and Lybrate, among others.

Why Purchase the Report?

  • To visualize the global medical second opinion market segmentation based on disorder, service provider, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of medical second opinion market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global medical second opinion market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Disorder
  • 3.2. Snippet by Service Type
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Safeguarding patients from misdiagnosis
      • 4.1.1.2. Increased Incidences of Neurological Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. The market's expansion is being hampered by the high cost of medical second opinions
    • 4.1.3. Opportunity
      • 4.1.3.1. Favorable government policies will create an opportunities for key players
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine Conflict Analysis

8. Artificial Intelligence Impact Analysis

9. By Disorder

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 9.1.2. Market Attractiveness Index, By Disorder
  • 9.2. Cancer
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diabetes
  • 9.4. Cardiac Disorders
  • 9.5. Neurological Disorders
  • 9.6. Ocular Disorders
  • 9.7. Others

10. By Service Type

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 10.1.2. Market Attractiveness Index, By Service Type
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Medical Second Opinion Providing Companies
  • 10.4. Health Insurance Companies

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.5.1. The U.S.
      • 11.2.5.2. Canada
      • 11.2.5.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.5.1. Germany
      • 11.3.5.2. The U.K.
      • 11.3.5.3. France
      • 11.3.5.4. Italy
      • 11.3.5.5. Spain
      • 11.3.5.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.5.1. Brazil
      • 11.4.5.2. Argentina
      • 11.4.5.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.5.1. China
      • 11.5.5.2. India
      • 11.5.5.3. Japan
      • 11.5.5.4. Australia
      • 11.5.5.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Mediguide International LLC.*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. WorldCare Inc.
  • 13.3. Cynergy Care
  • 13.4. AXA PPP Healthcare
  • 13.5. Cleveland Clinic
  • 13.6. Helsana Group
  • 13.7. Teladoc Health
  • 13.8. GrandOpinion
  • 13.9. Lybrate
  • 13.10. Mass General Brigham

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us